These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 2860913)

  • 21. [Comparative clinical studies on vecuronium, atracurium and pancuronium in older patients].
    Schaer H; Baasch K; Nassehi R
    Anaesthesist; 1984 Nov; 33(11):543-7. PubMed ID: 6151366
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacodynamics of vecuronium, atracurium, tubocurarine and their combinations in the rat in vivo.
    Booij LH; van Egmond J; van de Pol F; Crul JF
    Eur J Anaesthesiol; 1985 Sep; 2(3):279-84. PubMed ID: 2866094
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [A comparative study of atracurium, vecuronium and pancuronium using the rat phrenic nerve diaphragm preparation].
    Fukushima K; Aoki T; Ishikawa J
    Masui; 1985 Jan; 34(1):66-70. PubMed ID: 2860258
    [No Abstract]   [Full Text] [Related]  

  • 24. Dose-response relationships and neuromuscular blocking effects of vecuronium pancuronium during ketamine anaesthesia.
    Engbaek J; Ording H; Pedersen T; Viby-Mogensen J
    Br J Anaesth; 1984 Sep; 56(9):953-7. PubMed ID: 6147154
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of vecuronium, atracurium and tubocurarine in normal patients and in patients with no renal function.
    Hunter JM; Jones RS; Utting JE
    Br J Anaesth; 1984 Sep; 56(9):941-51. PubMed ID: 6147153
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Atracurium and vecuronium in emergency eye surgery.
    Mallaiah S; Eltringham RJ; Magauran DM
    Anaesthesia; 1986 Jan; 41(1):84-5. PubMed ID: 2868673
    [No Abstract]   [Full Text] [Related]  

  • 27. [Pharmacokinetics and pharmacodynamics of vecuronium in children].
    Steinbereithner K; Fitzal S; Schwarz S; Gilly H; Semsroth M; Weindlmayr-Goettel M
    Cah Anesthesiol; 1984; 32(1):5-10. PubMed ID: 6152193
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison between the continuous infusion of vecuronium and the intermittent administration of pancuronium and vecuronium.
    Noeldge G; Hinsken H; Buzello W
    Br J Anaesth; 1984 May; 56(5):473-7. PubMed ID: 6144316
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recovery characteristics following antagonism of atracurium with neostigmine or edrophonium.
    Jones RM; Pearce AC; Williams JP
    Br J Anaesth; 1984 May; 56(5):453-7. PubMed ID: 6326785
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of atracurium and vecuronium in patients with oesophageal varices.
    Bell CF; Hunter JM; Jones RS; Utting JE
    Br J Anaesth; 1985 Feb; 57(2):160-8. PubMed ID: 2857569
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of the pharmacology and vecuronium and atracurium with that of other currently available muscle relaxants.
    Hilgenberg JC
    Anesth Analg; 1983 May; 62(5):524-31. PubMed ID: 6132564
    [No Abstract]   [Full Text] [Related]  

  • 32. [Atracurium: neuromuscular blockade in repeated administration].
    Kube D; Schuh FT
    Anaesthesist; 1985 Dec; 34(12):639-44. PubMed ID: 2869712
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neuromuscular blocking effects of vecuronium and pancuronium during halothane anaesthesia.
    Engbaek J; Ording H; Viby-Mogensen J
    Br J Anaesth; 1983 Jun; 55(6):497-500. PubMed ID: 6134535
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Atracurium or vecuronium for rapid sequence endotracheal intubation.
    Lennon RL; Olson RA; Gronert GA
    Anesthesiology; 1986 Apr; 64(4):510-3. PubMed ID: 2870667
    [No Abstract]   [Full Text] [Related]  

  • 35. Precurarization with vecuronium and pancuronium in awake, healthy volunteers: the influence on neuromuscular transmission and pulmonary function.
    Engbaek J; Howardy-Hansen P; Ording H; Viby-Mogensen J
    Acta Anaesthesiol Scand; 1985 Jan; 29(1):117-20. PubMed ID: 2858145
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recovery times following edrophonium and neostigmine reversal of pancuronium, atracurium, and vecuronium steady-state infusions.
    Kopman AF
    Anesthesiology; 1986 Dec; 65(6):572-8. PubMed ID: 2878631
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intradermal histamine release by 3 muscle relaxants.
    Robertson EN; Booij LH; Fragen RJ; Crul JF
    Acta Anaesthesiol Scand; 1983 Jun; 27(3):203-5. PubMed ID: 6192671
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A comparison of the onset time, duration of action, and fade characteristics of atracurium and vecuronium.
    Haines M
    AANA J; 1993 Dec; 61(6):592-6. PubMed ID: 7903505
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The new neuromuscular blocking drugs are here.
    Savarese JJ
    Anesthesiology; 1981 Jul; 55(1):1-3. PubMed ID: 6113792
    [No Abstract]   [Full Text] [Related]  

  • 40. Presynaptic facilitatory adenosine A2A receptors mediate fade induced by neuromuscular relaxants that exhibit anticholinesterase activity.
    Bornia EC; Correia-de-Sá P; Alves-Do-Prado W
    Clin Exp Pharmacol Physiol; 2011 Mar; 38(3):164-9. PubMed ID: 21208254
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.